PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10500069-0	1999	Protection of trinitrobenzene sulfonic acid-induced colitis by an interleukin 2-IgG2b fusion protein in mice.	Trinitrobenzenesulfonic Acid	14-43	interleukin 2	Mus musculus	66-79	
10500069-7	1999	The protective role of IL-10 was demonstrated by the finding that neutralization of IL-10 in vivo using IL-10-specific antibodies inhibited the IL-2-IgG2b effects in TNBS-induced colitis.	Trinitrobenzenesulfonic Acid	166-170	interleukin 2	Mus musculus	144-148	
7595199-4	1995	Isolated lamina propria (LP) CD4+ T cells from TNBS-treated mice stimulated with anti-CD3 and anti-CD28 antibodies exhibited a Th1 pattern of cytokine secretion: a 20-50-fold increase in IL-2 and IFN-gamma levels and a 5-fold decrease in IL-4 levels as compared with those of stimulated LP CD4+ T cells from control BALB/c mice.	Trinitrobenzenesulfonic Acid	47-51	interleukin 2	Mus musculus	187-191	
8450204-16	1993	administration of TNBSA may, in part, be due to a PG-dependent suppressor factor that inhibits the responsiveness of target cells to IL-2.	Trinitrobenzenesulfonic Acid	18-23	interleukin 2	Mus musculus	133-137	
33717161-6	2021	Here, we show that treatment with LD IL-2 reduced 2,4,6-trinitrobenzensulfonic acid (TNBS) colitis severity in NOD.PrkdcscidIl2rg-/- (NSG) mice reconstituted with human CD34+ hematopoietic stem cells.	Trinitrobenzenesulfonic Acid	85-89	interleukin 2	Mus musculus	37-41